Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT06796660
Eligibility Criteria:
Inclusion Criteria:
1. Age between 18 and 65 years old (inclusive);
2. No gender restriction;
3. Patients diagnosed with CKD stages 2-4 according to the above diagnostic criteria by a specialist physician;
4. TCM syndrome differentiation is consistent;
5. Able to cooperate with the study treatment and follow-up, and has good compliance;
6. Agree and sign the medical informed consent form.
Exclusion Criteria:
1. Patients undergoing hemodialysis or peritoneal dialysis;
2. Patients with severe primary diseases of the cardiovascular, hematological, digestive, nervous, respiratory, endocrine systems, malignant tumors, etc.;
3. Patients in the active phase of autoimmune system diseases;
4. Patients with chronic infectious diseases such as active viral hepatitis, HIV, or active tuberculosis;
5. Patients with recent acute infections, and non-infectious complications such as hypertension and anemia that have not been effectively controlled;
6. Patients who have taken traditional Chinese medicine related to nephropathy treatment within the past month;
7. Patients who have undergone surgery, trauma, major bleeding, or blood transfusion within the past three months, or have severe clinical infections, electrolyte disturbances, and acid-base imbalances that have not been effectively controlled;
8. Pregnant or breastfeeding women;
9. Patients with mental disorders or poor compliance who cannot cooperate;
10. Patients who have participated in other drug tests within the past three months or have not completed the effective drug washout period. -
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06796660
Study Brief:
Protocol Section:
NCT06796660